In the 52-week study of more than 600 adults in China with type 2 diabetes, participants who received ecnoglutide saw their average blood sugar drop by about 1.9 percent, compared to a 1.65 percent drop in participants who received dulaglutide
Compounded semaglutide ensures that patients who cannot access branded medications still have a path to treatment
Retatrutide is investigational, not FDA-approved, and not commercially available
For patients, we would expect them to have better blood sugar control, more total body weight loss, and lower risk of cardiovascular disease. What happens if you stop taking Ozempic
It makes sense when you think about it like this - a study tracking skin texture over four weeks produces different data than one measuring hair density over 12 weeks
Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, Oude Egbrink MG